X-Feed Billboard (International)

The newsboard processes news from the NASDAQ Nordic portfolio company GlobeNewswire, which provides investors with company-relevant information. This relates in particular to events that may be relevant to the listing of companies or tradable financial instruments.

GlobNewswire (formerly PrimeNewswire) specializes in public relations solutions and digital media services. This feed adds another important source of information for investors to the popular X-Billboard portfolio.

System-State: Number of processed items 45.639 Notifications successully processed since Inception
GlobeNewsWire ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
CH0011432447
State: 10.01.2025 | 2PM
Do you already know our new terminal view? Click here.
FIGI: BBG000BWPGB1
BSLN

Basilea Pharmaceutica AG
GICS: 35201010 · Sector: - · Sub-Sector: -
NAME
Basilea Pharmaceutica AG
ISIN
CH0011432447
TICKER
BSLN
MIC
XSWX
REUTERS
BSLN.S
BLOOMBERG
BSLN SW
Wed, 08.01.2025       Basilea Pharmaceutica

Allschwil, Switzerland, January 08, 2025

Mon, 23.12.2024       Basilea Pharmaceutica

Ad hoc announcement pursuant to Art. 53 LR

Mon, 16.12.2024       Basilea Pharmaceutica

Ad hoc announcement pursuant to Art. 53 LR

Thu, 10.10.2024       Basilea Pharmaceutica

Allschwil, Switzerland, October 10, 2024

Tue, 24.09.2024       Basilea Pharmaceutica

Allschwil, Switzerland, September 24, 2024

Thu, 19.09.2024       Basilea Pharmaceutica

Ad hoc announcement pursuant to Art. 53 LR

Fri, 06.09.2024       Basilea Pharmaceutica

Ad hoc announcement pursuant to Art. 53 LR

Tue, 27.08.2024       Basilea Pharmaceutica

Ad hoc announcement pursuant to Art. 53 LR

Wed, 21.08.2024       Basilea Pharmaceutica

Allschwil, Switzerland, August 21, 2024

Tue, 13.08.2024       Basilea Pharmaceutica

Ad hoc announcement pursuant to Art. 53 LR

Thu, 20.06.2024       Basilea Pharmaceutica

Allschwil, Switzerland, June 20, 2024

Thu, 16.05.2024       Basilea Pharmaceutica

Allschwil, Switzerland, May 16, 2024

Fri, 03.05.2024       Basilea Pharmaceutica

Allschwil, Switzerland, May 03, 2024

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.


On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.